Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 1, Pages 93-93
http://dx.doi.org/10.1100/tsw.2001.192
Short Report

Transferrin Ensures Survival of Ovarian Carcinoma Cells Subjected to Deferoxamine, TNFA, FASL, Trail or MYC-Activation

1Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria
2Institute of Zoology, University of Vienna, A-1090 Vienna, Austria

Copyright © 2001 Georg Rosenberger et al.

Citations to this Article [1 citation]

The following is the list of published articles that have cited the current article.

  • David J. Villeneuve, Stacey L. Hembruff, Zachary Veitch, Melanie Cecchetto, William A. Dew, and Amadeo M. Parissenti, “cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance,” Breast Cancer Research and Treatment, vol. 96, no. 1, pp. 17–39, 2005. View at Publisher · View at Google Scholar